INTERVIEW: New CEO to push Avita out of stagnation
This article was originally published in Clinica
Executive Summary
Avita Medical Ltd, which has been incubating its ReCell skin regeneration technology for more than 20 years, is now close to seeing the therapy put to the wide-scale use it was intended for - helping victims of burns and other wounds grow back their skin quickly without significant scarring. This is thanks to a new $54m contract the Australian-listed company has secured with the US government.